EUVIMEDEUVIMED entdecken
Crossref

Relationship Between the Incidence of Metabolic Syndrome and Breast Cancer

Naoki Kimoto, Yohei Miyashita, Yutaka Yata, Takeshi Aketa, Masami Yabumoto, Yasushi Sakata, Takashi Washio, Seiji Takashima, Masafumi Kitakaze iD

Cardiovascular Drugs and Therapy · 2025

DOI: 10.1007/s10557-025-07780-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, 2025. Verfasst von Naoki Kimoto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Osaka University Graduate School of Medicine/Frontier Biosciences, 2-2, Suita, Osaka, Yamadaoka,, 565-0871, Japan. Hauptthemen laut MEDLINE: Metabolic Syndrome, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Japan Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Breast cancer affects females from puberty onward, with incidence rates increasing with age. Although metabolic syndrome (MetS) has reportedly increased the incidence of almost all cancers, no clear consensus on the role of MetS in breast cancer development exists. We aimed to clarify the effects of MetS on breast cancer incidence. METHODS: To investigate this relationship, we analyzed Japanese healthcare data of females from 2005 to 2020 and examined the incidence of breast cancer. MetS was evaluated based on the Japanese criteria or the NCEP ATP III guidelines at enrollment. Of 1,144,791 participants without missing data in our general public cohort, 32,775 with breast cancer at the beginning of the observation period were excluded; 54,330 participants with breast cancer were identified during the observation period. RESULTS: Both pre-stage MetS and MetS, defined using the Japanese criteria, were associated with the less frequent incidence of breast cancer (hazard ratios [HRs], 0.90; 95% CI, 0.86-0.94; p < 0.005: HR, 0.83; 95% CI, 0.80-0.87; p < 0.005). Furthermore, MetS using NCEP ATP III was associated with the lower HR (0.87: CI, 0.84-0.90; p < 0.005), and the number of the factors from 1 to 5 was gradually associated with the lower HRs. Analysis according to age group revealed that this observation was the most prominent in the < 50-year-old group. CONCLUSION: MetS is associated with the less frequent breast cancer incidence in females, especially aged < 50 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeBreast NeoplasmsHumansFemaleIncidenceMiddle AgedJapanAdultRisk FactorsAgedRisk Assessment

Stichwörter der Autor:innen

AgeBig dataBreast cancerEarly stage of metabolic syndromeMetabolic syndrome

Autor:innen und Institutionen

  • Department of Medical Biochemistry, Osaka University Graduate School of Medicine/Frontier Biosciences, 2-2, Suita, Osaka, Yamadaoka,, 565-0871, Japan.
  • Non Profit Organization Think of Medicine in Science, Minamisumiyoshi, 3-7-11, Osaka, Sumiyoshi-Ku, Japan.
  • Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita Osaka, Japan.
  • Hanwa Memorial Hospital, Minamisumiyoshi, 3-5-8, Sumiyoshi-Ku, Osaka, Japan.
  • ASCLEPIUS INC. , 3-6-2 Minamisumiyoshi, Sumiyoshi-Ku, Osaka, Japan.
  • The Institute of Scientific and Industrial Research, Osaka University, 1-1 Yamadaoka, Osaka, Suita, Japan.

ORCID-Profile: Masafumi Kitakaze

Förderung

  • Japan Heart Foundation

Zitieren

APA

Kimoto, N., Miyashita, Y., Yata, Y., Aketa, T., Yabumoto, M., Sakata, Y., Washio, T., Takashima, S., & Kitakaze, M. (2025). Relationship Between the Incidence of Metabolic Syndrome and Breast Cancer. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-025-07780-4

Vancouver

Kimoto N, Miyashita Y, Yata Y, Aketa T, Yabumoto M, Sakata Y, et al. Relationship Between the Incidence of Metabolic Syndrome and Breast Cancer. Cardiovascular Drugs and Therapy. 2025. doi:10.1007/s10557-025-07780-4

BibTeX
@article{Kimoto2025,
  author = {Kimoto, Naoki and Miyashita, Yohei and Yata, Yutaka and Aketa, Takeshi and Yabumoto, Masami and Sakata, Yasushi and Washio, Takashi and Takashima, Seiji and Kitakaze, Masafumi},
  title = {Relationship Between the Incidence of Metabolic Syndrome and Breast Cancer},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2025},
  doi = {10.1007/s10557-025-07780-4}
}
Kostenlos starten →